Vascular proteomics: linking proteomic and metabolomic changes

Manuel Mayr1, Ursula Mayr, Yuen-Li Chung

  • 1Department of Cardiac and Vascular Sciences, St George's Hospital Medical School, London, UK. m.mayr@sghms.ac.uk

Proteomics
|November 13, 2004
PubMed

Insights

Proteomics and metabolomics reveal molecular mechanisms of cardiovascular diseases. Combining these techniques offers deeper insights into arterial stiffness and atherosclerosis than either method alone.

Area of Science:

  • Cardiovascular Science
  • Proteomics
  • Metabolomics

Background:

  • Cardiovascular diseases are a leading cause of death, driven by stressors like hypertension and hypercholesterolemia.
  • These stressors cause arterial stiffness (arteriosclerosis) and lipid accumulation (atherosclerosis), but molecular mechanisms remain unclear.
  • Vascular proteomics is an emerging field, with limited studies applying proteomic techniques to vascular diseases.

Purpose of the Study:

  • To review the application of proteomics in studying vascular protein alterations.
  • To summarize progress in combining proteomic and metabolomic techniques for cardiovascular research.
  • To elucidate molecular mechanisms of atheroma formation and cardiovascular disease.

Main Methods:

  • Review of existing studies utilizing proteomics in vascular research.
  • Integration of proteomic and metabolomic analyses in cardiovascular systems.
  • Application of two-dimensional (2-D) gel electrophoresis and nuclear magnetic resonance (NMR) spectroscopy.

Main Results:

  • Two-dimensional (2-D) gel electrophoresis identified post-translational modifications of abundant enzymes.
  • Nuclear magnetic resonance (NMR) spectroscopy detected changes in corresponding metabolites.
  • Simultaneous proteomic and metabolomic assessment provided functional context and pathophysiological insights.

Conclusions:

  • Combining proteomics and metabolomics offers a powerful approach to understanding cardiovascular disease mechanisms.
  • This integrated strategy provides insights not achievable through single-technique analyses.
  • Further research integrating these 'omics' fields is crucial for advancing cardiovascular disease understanding and treatment.